Prediction of creatinine clearance from serum creatinine
For researchers, this means: Published Phase 3 trial data available for reference Well-characterized safety profile from prescription use Ongoing clinical trials for additional indications (NAFLD, cognitive function) Clear differentiation from research-only peptides like BPC-157 or TB-500 For comprehensive information on FDA-approved peptides across all therapeutic categories, see our FDA Approved Peptides List 2026 guide
Perilesional injection near injury sites may enhance local delivery for focal injuries
A Parsley Health clinician may take a personalized approach that includes: Reviewing metabolic markers such as blood sugar, insulin, and cholesterol Evaluating digestive health and gut-related symptoms that affect hormone signaling Assessing lifestyle factors like sleep, stress, physical activity, and meal timing Discussing food strategies that support satiety and metabolic stability Helping members patients navigate decisions around GLP-1 medications, including starting, continuing, or transitioning off them safely For individuals who have already explored GLP-1 medications elsewhere, Parsley Health often serves as a second-opinion or long-term support option
Naley jednak pamita, e brak jest danych z bada klinicznych u ludzi